AI and Precision Medicine in Infectious Disease Management
暫譯: 感染疾病管理中的人工智慧與精準醫療

Chen, Jen-Tsung

AI and Precision Medicine in Infectious Disease Management
  • 出版商: CRC
  • 出版日期: 2025-12-02
  • 售價: $5,160
  • 貴賓價: 9.5 折 $4,902
  • 語言: 英文
  • 頁數: 214
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 1041016212
  • ISBN-13: 9781041016212
  • 相關分類: Machine Learning

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book presents technical advancements of artificial intelligence (AI)-based technologies and computational biology approaches, highlighting their applications in developing smart healthcare and precision medicine for managing infectious diseases. It discusses cutting-edge AI tools, particularly machine and deep learning models, and generative AI, to assist in disease prediction and prevention, disease surveillance and diagnosis, drug discovery, drug design and development, healthcare, personalized medicine, pharmacology, and vaccine development. The contents fit the goal of establishing "Good Health and Well-Being," which is one of "The Sustainable Development Goals (SDGs) 2030".

Key Features:

  • Includes AI/omics approaches in precision medicine and smart healthcare

  • Summarizes AI-driven drug and vaccine developments and AI tools for infectious disease prevention for clinicians, researchers, and policymakers

  • Proposes AI-based strategies for disease prediction, surveillance, and diagnosis

商品描述(中文翻譯)

這本書介紹了基於人工智慧（AI）技術和計算生物學方法的技術進展，強調它們在開發智慧醫療和精準醫學以管理傳染病方面的應用。書中討論了尖端的AI工具，特別是機器學習和深度學習模型，以及生成式AI，以協助疾病預測和預防、疾病監測和診斷、藥物發現、藥物設計與開發、醫療保健、個人化醫療、藥理學和疫苗開發。內容符合建立「良好健康與福祉」的目標，這是「2030年可持續發展目標（SDGs）」之一。

主要特點：
- 包含精準醫學和智慧醫療中的AI/組學方法
- 總結了AI驅動的藥物和疫苗開發，以及針對臨床醫生、研究人員和政策制定者的傳染病預防AI工具
- 提出基於AI的疾病預測、監測和診斷策略

作者簡介

Dr. Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan, where he teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen's research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, ethnopharmacology, and systems biology. He serves as an editorial board member in reputed journals, including Plant Methods, GM Crops & Food, Plant Nano Biology, Biomolecules, International Journal of Molecular Sciences, and as a guest editor in Frontiers in Plant Science, Frontiers in Pharmacology, Journal of Fungi, and Current Pharmaceutical Design. Dr. Chen published books in collaboration with Springer Nature, CRC Press/Taylor & Francis Group, and CABI, and he is handling book projects for some more international publishers on topics of bioinformatics, drug discovery, epigenetics, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, and CRISPR-based plant genome editing. In 2023 and 2024, Elsevier and Stanford University recognized Dr. Chen as one of the "World's Top 2% Scientists". Dr. Chen received the Springer Nature Editor of Distinction Award in 2025.

作者簡介(中文翻譯)

陳仁宗博士是台灣高雄大學的細胞生物學教授，教授細胞生物學、基因組學、蛋白質組學、植物生理學和植物生物技術。陳博士的研究興趣包括生物活性化合物、色譜技術、植物分子生物學、植物生物技術、生物資訊學和系統藥理學。他積極擔任學術書籍和期刊的編輯，以推進涉及植物生理學、植物生物技術、納米技術、民族藥理學和系統生物學的多學科知識探索。他是多本知名期刊的編輯委員會成員，包括《Plant Methods》、《GM Crops & Food》、《Plant Nano Biology》、《Biomolecules》、《International Journal of Molecular Sciences》，並擔任《Frontiers in Plant Science》、《Frontiers in Pharmacology》、《Journal of Fungi》和《Current Pharmaceutical Design》的客座編輯。陳博士與Springer Nature、CRC Press/Taylor & Francis Group和CABI合作出版書籍，並正在為一些國際出版社處理有關生物資訊學、藥物發現、表觀遺傳學、納米技術、生物工程、植物功能基因組學、植物快速育種和基於CRISPR的植物基因組編輯的書籍項目。2023年和2024年，Elsevier和史丹佛大學將陳博士評選為「全球前2%科學家」之一。陳博士於2025年獲得Springer Nature卓越編輯獎。

類似商品